AGP Picks
View all

Haiti, Science, & Me: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Haiti, Science, & Me.

Press releases published on October 29, 2026

Jitterbit setzt voll auf Partner – und belohnt sie entsprechend
Jitterbit Betting Big on Partners, and Pays Them Like It
Helsinn announces UK MHRA approval of AKYNZEO® Oral Suspension
Dayforce Turns the Sounds of the Modern Workplace into a Musical Experience with Workestra
AllPredictions.io Is Evolving From a Prediction Market Dashboard Into an Arbitrage Discovery Tool
The Living Room Gets a Guest Room: HONBAY’s New Altus and Vora Modular Sleeper Sectionals Turn the Couch Into a Bed
Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit
Pacera launches Pacera Lease by AARO in the UK, bringing more than 30 years of AARO accounting heritage to FRS 102 lease reporting.
IPQS Says Agent Authorization Alone Won’t Secure Agentic Commerce
Madronus and NPHS Launch Wildfire Resilience Loans to Help California Homeowners Access Insurance and Reduce Costs
Exogenus Therapeutics leads a €13 million EU-funded consortium to advance a new secretome-based therapy for osteoarthritis
ALLOX closes $10.5M seed financing and appoints Morten Graugaard as Chair to scale allosteric drug discovery platform and build pipeline
Virtune listet Virtune Staked NEAR ETP an der Deutschen Börse Xetra in Deutschland
Virtune lists Virtune Staked NEAR ETP on Deutsche Börse Xetra in Germany
ADDEX INCREASES ISSUED SHARE CAPITAL  TO CREATE TREASURY SHARES
TORRAS Offers a Halloween Treat With 15% Off Select iPhone 18 Pro Max Cases
Crypto Market News: AlphaPepe Eyes Tier 1 CEX Listing as Bitcoin Price Prediction Reacts to Iran War Headlines
Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application of Toripalimab (Subsutaneous Injection) for the 1st-Line Treatment of HER2-Expressing Urothelial Carcinoma
Activity Report for Quarter Ended September 30, 2026 (Appendix 4C)
HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Primary Immune Thrombocytopenia

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Haiti, Science, & Me

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.